14th ICID - Poster Abstracts - International Society for Infectious ...

More documents

Recommendations

Info

When citing these abstracts please use the following reference: Author(s) of abstract. Title of abstract [abstract]. Int J Infect Dis 2010;14S1: Abstract number. Please note that the official publication of the International Journal of Infectious Diseases 2010, Volume 14, Supplement 1 is available electronically on http://www.sciencedirect.com Final Abstract Number: 32.004 Session: Travel Medicine and Travel Health Date: Wednesday, March 10, 2010 Time: 12:30-13:30 Room: Poster & Exhibition Area/Ground Level Type: Poster Presentation Demographics, medical conditions, and use of immunizations and chemoprophylaxis among international travelers within the Global TravEpiNet U.S. National Clinic Network R. LaRocque 1 , S. Rao 1 , E. Yanni 2 , N. Marano 3 , N. Gallagher 3 , C. Marano 3 , G. Brunette 3 , J. Lee 4 , V. Ansdell 5 , B. S. Schwartz 6 , M. Knouse 7 , J. Cahill 8 , S. Hagmann 9 , J. Vinetz 10 , R. Hoffman 11 , S. Alvarez 12 , J. Goad 13 , C. Franco-Paredes 14 , P. Kozarsky 14 , D. Schoenfeld 1 , E. Ryan 1 1 Massachusetts General Hospital, Boston, MA, USA, 2 Centers for Disease Control and Prevention, Atlanta, GA, USA, 3 Centers for Disease Control & Prevention, Atlanta, GA, USA, 4 Travel and Immunization Center, Northwestern Memorial Hospital, Chicago, IL, USA, 5 Kaiser Permanente Honolulu Travel Medicine Clinic, Honolulu, HI, USA, 6 University of California-San Francisco Travel Medicine & Immunizatiion Center, San Francisco, CA, USA, 7 Keystone Travel Medicine, Lehigh Valley Medical Center, Allenton, PA, USA, 8 Travel & Immunization Center, St Luke's Roosevelt, New York, NY, USA, 9 Bronx Lebanon Hospital Center Neighborhod Clinic for Travel Health, Bronx, NY, USA, 10 University of California, San Diego Travel Clinic, La Jolla, CA, USA, 11 University of California Los Angeles Travel & Tropical Medicine Clinic, Los Angeles, CA, USA, 12 Mayo Clinic, Jacksonville, FL, USA, 13 USC International Travel Medicine Clinic, Los Angeles, CA, USA, 14 Emory TravelWell, Atlanta, GA, USA Background: International travelers play a significant role in the global spread of infectious diseases. Despite this, data are limited on travel patterns, medical conditions, and medical interventions among international travelers prior to departure. Methods: Global TravEpiNet is a U.S. CDC-sponsored network of U.S. clinics that care for international travelers. We report analysis of health data for 3,159 international travelers seen at U.S. Global TravEpiNet sites in 2009. Results: Females accounted for 56% of travelers. The median age was 33 years; the median duration of travel was 14 days. Thirty-five percent of international travelers were traveling to lowincome countries, 46% to low-middle income, 16% to upper-middle income, and 2% to upperincome countries. The main purposes of travel were vacation/leisure (63%), business (20%), extreme-adventure travel (14%), education/research (11%), visiting friends and relatives (10%), non-medical service work (6%), and providing medical care (4%). Two percent of travelers were attending large gatherings. Ten percent were children less than 18 years of age; 4% were less than 5 years of age; and 6% of travelers were over 65 years of age. Sixty-four percent of travelers listed a medical condition; 70% were on daily medication. Ten percent of travelers reported a pre-existing neurologic or psychiatric condition; 7% reported a pre-existing intestinal condition; 2.5% were immunocompromised; and 0.4% of female travelers were pregnant or breastfeeding. We analyzed vaccine usage for prevention of hepatitis A, yellow fever, and influenza. Eighty-one percent of travelers received immunization against hepatitis A; 7% were considered pre-immune. Of the 38% of travelers visiting countries that included areas endemic for yellow fever, 67% received yellow fever immunization; 18% were considered pre-immune. Yellow fever vaccine was administered to 407 travelers 60 years of age or older. Forty percent of international travelers received influenza vaccine; 30% were considered pre-immune. Of the 2082 travelers traveling to countries that included areas endemic for malaria, 65% received malaria chemoprophylaxis. Of these, 66% received prescriptions for atovaquone-proguanil, 3.5% received doxycycline, and 14% received mefloquine. Conclusion: These data suggest that international travelers range widely in age and frequently have co-morbid medical conditions that heighten the need for pre-travel advice.
When citing these abstracts please use the following reference: Author(s) of abstract. Title of abstract [abstract]. Int J Infect Dis 2010;14S1: Abstract number. Please note that the official publication of the International Journal of Infectious Diseases 2010, Volume 14, Supplement 1 is available electronically on http://www.sciencedirect.com Final Abstract Number: 32.005 Session: Travel Medicine and Travel Health Date: Wednesday, March 10, 2010 Time: 12:30-13:30 Room: Poster & Exhibition Area/Ground Level Type: Poster Presentation Use and sources of medical information among departing international travelers to low and middle income countries at Logan International Airport-Boston, MA, 2009 R. LaRocque 1 , S. Rao 1 , T. Lawton 1 , A. Tsibris 1 , D. Schoenfeld 1 , A. Barry 2 , E. Yanni 3 , N. Marano 4 , N. Gallagher 4 , C. Marano 4 , G. Brunette 4 , E. Ryan 1 1 Massachusetts General Hospital, Boston, MA, USA, 2 Communicable Disease Control, Boston Public Health Commission, Boston, MA, USA, 3 Centers for Disease Control and Prevention, Atlanta, GA, USA, 4 Centers for Disease Control & Prevention, Atlanta, GA, USA Background: International travelers play a significant role in the global spread of infectious diseases, especially travelers to low and middle-income countries (LMICs). Despite this, limited data exist on sources of health information used by these travelers. Methods: To address this, we surveyed 1,254 international travelers who reside in the U.S. and were departing from Boston-Logan International Airport in 2009. Results: Of the 1,254 travelers, 671 (54%) were traveling to LMICs. The mean age of travelers to LMICs was 42 years, and 30% were traveling for more than 2 weeks. Purposes of travel included vacation/holiday (63%), business/work (11%), educational/cultural exchange (6%), performing volunteer work (10%), adventuring (7%), attending a large gathering (2%), providing medical care (3%), receiving medical care (0.5%), and adoption (0.3%). Nineteen percent were traveling as part of a family that included children, and 104 (16%) were born overseas and returning to visit friends or relatives (VFRs). Among travelers to LMICs, 50% did not seek any medical advice and 74% did not see a healthcare professional prior to travel. For travelers who did not seek medical advice, the most common reasons cited were lack of concern about health issues (60%), not thinking of it (35%), not having enough time (7%), inconvenience (3%), and expense (2%). A significantly lower percentage of VFRs sought any-source medical advice prior to travel compared with other travelers (37% vs 52%; p=0.004). VFRs were less likely than other travelers to use the Internet (12% vs 24%; p=0.004), and less likely to see a specialist practitioner prior to travel (2% vs. 15%; P
Page 1 and 2:
When citing these abstracts please
Page 3 and 4:
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170: When citing these abstracts please
Page 219: When citing these abstracts please
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299:
show all

14th ICID - Poster Abstracts - International Society for Infectious ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?